Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00263458
Status:
COMPLETED
Last Update Posted:
2011-09-12
First Post:
2005-12-06
Brief Title:
Integrating Buprenorphine Into the SFGH AIDS Program
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Study Overview
Official Title:
Integrating Buprenorphine Into the SFGH AIDS Program Patient Evaluation Study
Status:
COMPLETED
Status Verified Date:
2011-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BHIVES-SF
Brief Summary:
The purpose of this study is to assess the feasibility cost and effectiveness of a model of care designed to integrate buprenorphine treatment for opioid dependence into the HIV primary care clinics at the UCSF Positive Health Program
Detailed Description:
The UCSF Positive Health Program formerly called the AIDS Program at San Francisco General Hospital SFGH is one of the oldest and largest HIVAIDS clinics in the United States Located at the public hospital serving medically indigent residents of San Francisco the Positive Health Program PHP provides over 2000 patient visits per month to 2300 patients in a comprehensive HIV primary care setting The clinic population is disproportionately affected by heroin and other opiate abuse problems Opiate replacement therapy ORT has a stabilizing effect in HIV-infected injecting drug users IDU and is associated with greater acceptance of antiretroviral ARV therapy higher ARV adherence and greater engagement in appropriate HIV-related health care However there are insufficient resources to meet the critical substance abuse treatment needs among our opioid-dependent patients
In partnership with the Community Behavioral Health Services CBHS section of the San Francisco Department of Public Health SFDPH the UCSF Positive Health Program PHP at San Francisco General Hospital SFGH has developed a model of care which provides opioid-dependent patients with integrated office-based buprenorphine ORT in the HIV primary care setting The program also offers primary care providers with education and training on addiction opiate addiction treatment and the appropriate use of buprenorphine An evaluation of the program is planned to examine 1 its effects on the health and substance use of patients 2 program costs and 3 what broader impact the program has on providers institutions and local systems In the patient evaluation study eligible opioid-dependent patients that receive primary HIV care at the PHP will be randomly assigned to receive buprenorphine ORT for twelve months either in the integrated HIV primary care setting intervention group versus a non-integrated substance abuse treatment clinic setting comparison group Data will be abstracted from medical chart reviews and will be collected from patients using standardized instruments and satisfaction surveys
In partnership with the Community Behavioral Health Services CBHS section of the San Francisco Department of Public Health SFDPH the UCSF Positive Health Program PHP at San Francisco General Hospital SFGH has developed a model of care which provides opioid-dependent patients with integrated office-based buprenorphine ORT in the HIV primary care setting The program also offers primary care providers with education and training on addiction opiate addiction treatment and the appropriate use of buprenorphine An evaluation of the program is planned to examine 1 its effects on the health and substance use of patients 2 program costs and 3 what broader impact the program has on providers institutions and local systems In the patient evaluation study eligible opioid-dependent patients that receive primary HIV care at the PHP will be randomly assigned to receive buprenorphine ORT for twelve months either in the integrated HIV primary care setting intervention group versus a non-integrated substance abuse treatment clinic setting comparison group Data will be abstracted from medical chart reviews and will be collected from patients using standardized instruments and satisfaction surveys
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None